Published in Exp Neurol on September 01, 1994
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A (1991) 3.85
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A (1994) 2.39
Oxidative alterations in Alzheimer's disease. Brain Pathol (1999) 2.21
Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci U S A (1990) 2.18
Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem (1995) 1.84
Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol (1992) 1.65
Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosci Lett (1988) 1.38
3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sci (1988) 1.26
Caloric restriction mimetics: metabolic interventions. J Gerontol A Biol Sci Med Sci (2001) 1.22
Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons. Exp Neurol (1995) 1.16
Histopathology of pressure ulcers as a result of sequential computer-controlled pressure sessions in a fuzzy rat model. Adv Wound Care (1994) 1.09
Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users. J Acquir Immune Defic Syndr (2001) 1.07
Survival of HIV-1 in syringes: effects of temperature during storage. Subst Use Misuse (2000) 1.06
Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures. J Neurochem (1996) 1.05
Ischemia/reperfusion-induced changes in membrane proteins and lipids of gerbil cortical synaptosomes. Neuroscience (1995) 1.02
Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS (1998) 1.01
Protein modification in aging. EXS (1992) 0.99
Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders. Dement Geriatr Cogn Disord (1999) 0.99
Basic FGF, NGF, and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J Cereb Blood Flow Metab (1993) 0.98
Elevated oxidative stress in models of normal brain aging and Alzheimer's disease. Life Sci (1999) 0.96
Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. J Neurochem (1997) 0.95
Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone. Proc Natl Acad Sci U S A (1997) 0.94
Histologic responses of port-wine stains treated by argon, carbon dioxide, and tunable dye lasers. A preliminary report. Arch Dermatol (1986) 0.93
Tunable dye laser (577 nm) treatment of port wine stains. Lasers Surg Med (1986) 0.92
An animal model and computer-controlled surface pressure delivery system for the production of pressure ulcers. J Rehabil Res Dev (1995) 0.92
The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease. Exp Neurol (1997) 0.91
Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey. Pharmacol Biochem Behav (1977) 0.91
Protein oxidation in aging brain. Ann N Y Acad Sci (1992) 0.91
Opioids disrupt Ca2+ homeostasis and induce carbonyl oxyradical production in mouse astrocytes in vitro: transient increases and adaptation to sustained exposure. Exp Neurol (1998) 0.90
Age influence on oxidative events during brain ischemia/reperfusion. Arch Gerontol Geriatr (2004) 0.90
Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro. Anticancer Drugs (1999) 0.90
Protein oxidation and enzyme activity decline in old brown Norway rats are reduced by dietary restriction. Mech Ageing Dev (1998) 0.89
Antioxidants protect against reactive oxygen species associated with adriamycin-treated cardiomyocytes. Cancer Lett (1999) 0.89
Genetic analysis of sensitization and tolerance to cocaine. J Pharmacol Exp Ther (1994) 0.89
Nitrone-based free radical traps as neuroprotective agents in cerebral ischaemia and other pathologies. Int Rev Neurobiol (1997) 0.88
Comparison of cocaine and GBR 12935: effects on locomotor activity and stereotypy in two inbred mouse strains. Pharmacol Biochem Behav (1994) 0.88
beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease. Neuroreport (1995) 0.87
Measles-specific lymphocyte reactivity and serum antibody in subjects with different measles histories. Am J Dis Child (1980) 0.87
Genetic determinants of susceptibility to the rewarding and other behavioral actions of cocaine. J Addict Dis (1991) 0.87
Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation. J Neurochem (1996) 0.86
Effects of caffeine, theophylline and theobromine on scheduled controlled responding in rats. Br J Pharmacol (1982) 0.86
Aging and caloric restriction affect mitochondrial respiration and lipid membrane status: an electron paramagnetic resonance investigation. Free Radic Biol Med (1997) 0.86
Antitumor activity of tricyclic pyrone analogs, a new synthetic class of microtubule de-stabilizing agents, in the murine EMT-6 mammary tumor cell line in vitro. Anticancer Drugs (1998) 0.85
Effects of mitochondrial respiratory stimulation on membrane lipids and proteins: an electron paramagnetic resonance investigation. Biochim Biophys Acta (1998) 0.84
Alpha 1-antichymotrypsin interaction with A beta (1-42) does not inhibit fibril formation but attenuates the peptide toxicity. Neurosci Lett (1996) 0.84
Scanning and transmission electron microscopic aspects of the nasal acilia syndrome. Laryngoscope (1982) 0.84
Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics. J Neuropathol Exp Neurol (1998) 0.84
Membrane protein alterations in rodent erythrocytes and synaptosomes due to aging and hyperoxia. Biochim Biophys Acta (1995) 0.83
A beta (25-35) peptide displays H2O2-like reactivity towards aqueous Fe2+, nitroxide spin probes, and synaptosomal membrane proteins. Life Sci (1996) 0.83
Increased in vitro lipid peroxidation of gerbil cerebral cortex as compared with rat. Neurosci Lett (1986) 0.83
Behavioral interaction between cocaine and caffeine: a drug discrimination analysis in rats. Pharmacol Biochem Behav (1989) 0.83
Sensitization to stereotypy in DBA/2J but not C57BL/6J mice with repeated cocaine. Pharmacol Biochem Behav (1994) 0.83
Amyloid beta-peptide inhibits Na+-dependent glutamate uptake. Life Sci (1999) 0.82
Adriamycin-induced changes of creatine kinase activity in vivo and in cardiomyocyte culture. Toxicology (1999) 0.82
Inherent differences in sensitivity to methylxanthines among inbred mice. Pharmacol Biochem Behav (1986) 0.82
Cell-mediated immune defects and infection. A study of malnourished hospitalized children. Am J Dis Child (1980) 0.82
The role of metal ions in oxidative processes and aging. Toxicol Ind Health (1993) 0.81
Interstrain variation in acute toxic response to caffeine among inbred mice. Pharmacol Biochem Behav (1984) 0.81
An unanesthetized-gerbil model of cerebral ischemia-induced behavioral changes. J Pharmacol Methods (1985) 0.81
Caffeine discrimination in the rat. Pharmacol Biochem Behav (1981) 0.81
Use of bleach to disinfect HIV-1 contaminated syringes. Am Clin Lab (2001) 0.81
Effects of caffeine, cocaine and their combination on fixed-interval behavior in rats. Pharmacol Biochem Behav (1989) 0.81
Ischemic induction of protooncogene expression in gerbil brain. J Mol Neurosci (1991) 0.81
alpha-1-antichymotrypsin interaction with A beta (1-40) inhibits fibril formation but does not affect the peptide toxicity. Neurosci Lett (1996) 0.80
Effects of morphine and two enzyme resistant enkephalins on schedule-controlled responding in the rat. Pharmacol Biochem Behav (1978) 0.79
Differential antagonism of the behavioral depressant and hypothermic effects of 5'-(N-ethylcarboxamide) adenosine by theobromine. Pharmacol Biochem Behav (1986) 0.79
Discriminative stimulus properties of methylxanthines and their metabolites in rats. Life Sci (1985) 0.79
Modulation of ornithine decarboxylase mRNA following transient ischemia in the gerbil brain. J Cereb Blood Flow Metab (1991) 0.79
Brain creatine kinase with aging in F-344 rats: analysis by saturation transfer magnetic resonance spectroscopy. Neurobiol Aging (1998) 0.79
Antagonism of the behavioral effects of L-phenylisopropyladenosine (L-PIA) by caffeine and its metabolites. Pharmacol Biochem Behav (1984) 0.79
Enhancement of beta-amyloid peptide A beta(1-40)-mediated neurotoxicity by glutamine synthetase. J Neurochem (1995) 0.78
Inherent hyporesponsiveness to methylxanthine-induced behavioral changes associated with supersensitivity to 5'-N-ethylcarboxamidoadenosine (NECA). Pharmacol Biochem Behav (1986) 0.78
Sensitivity of inbred mice to methylxanthines is not determined by plasma xanthine concentration. Neurosci Lett (1985) 0.78
Corneal effect of isotretinoin: possible exacerbation of corneal neovascularization in a patient with the keratitis, ichthyosis, deafness ("KID") syndrome. J Am Acad Dermatol (1986) 0.78
Exercise-induced changes in schedule controlled behavior. Physiol Behav (1985) 0.78
Adriamycin induces protein oxidation in erythrocyte membranes. Pharmacol Toxicol (1998) 0.78
Structural alterations in synaptosomal membrane-associated proteins and lipids by transient middle cerebral artery occlusion in the cat. Neurochem Res (1995) 0.78
Variable interval responding maintained by intravenous codeine and ethanol injections in the rhesus monkey. Pharmacol Biochem Behav (1976) 0.78
Effects of systemic and intraventricular administration of cannabinoids on schedule-controlled responding in the squirrel monkey. J Pharmacol Exp Ther (1979) 0.77
Evaluation of ibuprofen for pressure ulcer prevention: application of a rat pressure ulcer model. Adv Wound Care (1995) 0.77
Changes in drug sensitivity following acute and chronic exercise. Pharmacol Biochem Behav (1985) 0.77
Antagonism by CGS 8216 and Ro 15-1788, benzodiazepines antagonists, of the action of chlordiazepoxide on a timing behavior in rats. Pharmacol Biochem Behav (1984) 0.77
Locomotor stimulant effects of cocaine and novel cocaine analogs in DBA/2J and C57BL/6J inbred mice. Pharmacol Biochem Behav (1995) 0.77
Prevention of ischemia/reperfusion-induced alterations in synaptosomal membrane-associated proteins and lipids by N-tert-butyl-alpha-phenylnitrone and difluoromethylornithine. Neuroscience (1995) 0.77
Characterization of the antitumor-promoting activity of camptothecin in SENCAR mouse skin. Carcinogenesis (1996) 0.76
Oxidative modification of glutamine synthetase by amyloid beta peptide. Free Radic Res (1997) 0.76
Inheritance of amphetamine-induced thermoregulatory responses in inbred mice. Pharmacol Biochem Behav (1985) 0.76
1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro. Anticancer Drugs (2000) 0.76
Effects of selected analogs of adenosine on schedule-controlled behavior in rats. Neuropharmacology (1986) 0.76
Camptothecin post-treatments inhibit the biochemical events linked to the tumor-promoting component of carcinogenesis in mouse epidermis in vivo. Int J Cancer (1996) 0.76
Amyloid beta-peptide spin trapping. I: Peptide enzyme toxicity is related to free radical spin trap reactivity. Neuroreport (1995) 0.76
Age effect on brain pH during ischemia/reperfusion and pH influence on peroxidation. Neurobiol Aging (1995) 0.76
Stereospecific dextrorphan tolerance in rats. Br J Pharmacol (1981) 0.75
Barbitone-induced tolerance to the effects of sedative-hypnotics and related compounds on operant behaviour in the rat. Br J Pharmacol (1979) 0.75
Systematic comparison of apomorphine-induced behavioral changes in two mouse strains with inherited differences in brain dopamine receptors. Pharmacol Biochem Behav (1984) 0.75
A potent antinociceptive cannabinoid which lacks opiate substitution properties in monkeys. Res Commun Chem Pathol Pharmacol (1977) 0.75
Aldose reductase inhibitors and nanodelivery of diabetic therapeutics. Mini Rev Med Chem (2012) 0.75
Pargyline-induced increases in sensitivity to the effects of drugs on operant behavior in pigeons. Psychopharmacology (Berl) (1977) 0.75